The influence of D. chrysotoxum on hepatocellular carcinoma inhibition may depend on making an impact on EGFR tyrosine kinase inhibitor resistance pathway and FoX O signaling pathway. The gene discussed is EGFR; the disease is hepatocellular carcinoma.